EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access

Effect of graduated drug therapy for moderate-to-severe chronic insomnia on the severity of disease: an observational study in Germany

Jolijn Boer, Theresa Toncar, Arne Stange, Lisa Rosenblum, Ingo Fietze

Journal of Clinical Sleep Medicine · 2025

DOI: 10.5664/jcsm.11334 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Clinical Sleep Medicine, 2025. Verfasst von Jolijn Boer und 4 weiteren Autor:innen. Beteiligte Einrichtung: Interdisziplinäres Schlafmedizinisches Zentrum, Charité - Universitätsmedizin Berlin, Berlin, Germany. Hauptthemen laut MEDLINE: Severity of Illness Index, Sleep Initiation and Maintenance Disorders. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

STUDY OBJECTIVES: Severe chronic insomnia is a common sleep disorder that is mostly persistent and needs to be treated. Pharmacologic treatment options and guidelines are sparse, particularly for long-term treatment. Our study aimed to investigate a graduated therapy scheme for moderate-to-severe chronic insomnia in practice, considering the effects on self-reported sleep quality and quality of life. METHODS: Patients with moderate-to-severe chronic insomnia were given appropriate medication according to a graduated therapy scheme, ranging from l-tryptophan (as the first choice, least potent) to Z-drugs and combination therapies (as the last option, most potent). Each step of the graduated therapy scheme was tested for at least 4 weeks. Data related to sleep and quality of life were collected in questionnaire form (Insomnia Severity Index, Pittsburgh Sleep Quality Index, Beck Depression Inventory, second edition, and Short Form 36 Health Survey) at baseline and during the course of the treatment after 1, 3, 6, 9, and 12 months. RESULTS: Of 86 eligible patients, 60.5% started treatment with l-tryptophan and 8.1% with melatonin. After 3 months, 12.5% were still taking l-tryptophan and 12.5% were taking melatonin. There was a significant decrease in mean Insomnia Severity Index, Pittsburgh Sleep Quality Index, Beck Depression Inventory, second edition, and Short Form 36 Health Survey scores after 3 months of treatment for all patients in the study (n = 64). After 6 months, 22.2% were still taking l-tryptophan, melatonin, or agomelatine, and the remainder had switched to more potent drugs such as antidepressants, hypnotics, daridorexant, or combination therapies. CONCLUSIONS: A significant number of patients already responded favorably to mild sleep medications, whereas others demonstrated a need for more potent treatments. Ongoing monitoring will evaluate the long-term effectiveness of both approaches. CLINICAL TRIAL REGISTRATION: Registry: German Clinical Trials Register; Name: Schlafqualität und Lebensqualität mit einer medikamentösen Langzeittherapie bei moderater bis schwerer Insomnie; URL: https://drks.de/search/de/trial/DRKS00033175; Identifier: DRKS00033175. CITATION: Boer J, Toncar T, Stange A, Rosenblum L, Fietze I. Effect of graduated drug therapy for moderate-to-severe chronic insomnia on the severity of disease: an observational study in Germany. J Clin Sleep Med. 2025;21(1):33-45.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Severity of Illness IndexSleep Initiation and Maintenance DisordersAdultFemaleHumansMaleMiddle AgedAcetamidesChronic DiseaseDrug Therapy, CombinationGermanyHypnotics and SedativesMelatoninQuality of LifeSleep QualitySurveys and QuestionnairesTreatment OutcomeTryptophanNaphthalenes

Stichwörter der Autor:innen

drug treatmentinsomniainsomnia severity indexpharmacotherapysleep

Substanzen

AcetamidesHypnotics and SedativesMelatoninTryptophanagomelatineNaphthalenes

Autor:innen und Institutionen

  • Interdisziplinäres Schlafmedizinisches Zentrum, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Southwest Medical University Affiliated Zigong Hospital, Luzhou, China.

Zitieren

APA

Boer, J., Toncar, T., Stange, A., Rosenblum, L., & Fietze, I. (2025). Effect of graduated drug therapy for moderate-to-severe chronic insomnia on the severity of disease: an observational study in Germany. Journal of Clinical Sleep Medicine. https://doi.org/10.5664/jcsm.11334

Vancouver

Boer J, Toncar T, Stange A, Rosenblum L, Fietze I. Effect of graduated drug therapy for moderate-to-severe chronic insomnia on the severity of disease: an observational study in Germany. Journal of Clinical Sleep Medicine. 2025. doi:10.5664/jcsm.11334

BibTeX
@article{Boer2025,
  author = {Boer, Jolijn and Toncar, Theresa and Stange, Arne and Rosenblum, Lisa and Fietze, Ingo},
  title = {Effect of graduated drug therapy for moderate-to-severe chronic insomnia on the severity of disease: an observational study in Germany},
  journal = {Journal of Clinical Sleep Medicine},
  year = {2025},
  doi = {10.5664/jcsm.11334}
}
Kostenlos starten →